BBV152/BBV154 Heterologus Prime-Boost Study

NCT05639998 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

608

Enrollment

INDUSTRY

Sponsor class

Conditions

Corona Virus Infection

Interventions

BIOLOGICAL: COVAXIN(BBV152)
BIOLOGICAL: BBV154 Intranasal Vaccine

Sponsor

Bharat Biotech International Limited